Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: A phase 3 randomised, double-blind, placebo-controlled trial

David Michelson, Ellen Snyder, Erin Paradis, Mary Chengan-Liu, Duane B. Snavely, Jill Hutzelmann, James K. Walsh, Andrew D. Krystal, Ruth M. Benca, Martin Cohn, Christopher Lines, Thomas Roth, W. Joseph Herring

Research output: Contribution to journal › Article › peer-review

185 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: A phase 3 randomised, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences